No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Jul 2025.
Get an email when SNYR's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 – Jul 30, 2025 | Jack Ross CEO and Chairman | Bought 24 parts | 27,900 | $2.85 average | 80K | 0.6% | Form 4 |
| Jun 2, 2025 – Jun 10, 2025 | Jack Ross CEO and Chairman | Bought 6 parts | 16,100 | $1.85 average | 30K | 0.3% | Form 4 |
| Apr 11, 2025 – May 15, 2025 | Jack Ross CEO and Chairman | Bought 12 parts | 5,300 | $2.05 average | 11K | 0.1% | Form 4 |
| Feb 21, 2025 – Apr 10, 2025 | Jack Ross CEO and Chairman | Bought 30 parts | 14,340 | $2.74 average | 39K | 4.1% | Form 4 |
| Jan 23, 2025 – Feb 21, 2025 | Jack Ross CEO and Chairman | Bought 20 parts | 15,200 | $3.92 average | 60K | 0.3% | Form 4 |
| Nov 25, 2024 – Jan 22, 2025 | Jack Ross CEO and Chairman | Bought 30 parts | 5,170 | $4.92 average | 25K | 1.6% | Form 4 |
- Jun 11, 2025 – Jul 30, 2025Jack RossCEO and Chairman · bought 27,900 at avg $2.8580K0.6% of stake
- Jun 2, 2025 – Jun 10, 2025Jack RossCEO and Chairman · bought 16,100 at avg $1.8530K0.3% of stake
- Apr 11, 2025 – May 15, 2025Jack RossCEO and Chairman · bought 5,300 at avg $2.0511K0.1% of stake
- Feb 21, 2025 – Apr 10, 2025Jack RossCEO and Chairman · bought 14,340 at avg $2.7439K4.1% of stake
- Jan 23, 2025 – Feb 21, 2025Jack RossCEO and Chairman · bought 15,200 at avg $3.9260K0.3% of stake
- Nov 25, 2024 – Jan 22, 2025Jack RossCEO and Chairman · bought 5,170 at avg $4.9225K1.6% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Medicinal Chemicals & Botanical Products · Pick stocks to compare with SNYR
Spot a number that looks wrong? Check it in SNYR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SNYR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.